Author:
Nakajima Kenichi,Edenbrandt Lars
Reference34 articles.
1. Nakajima K, Edenbrandt L, Mizokami A. Bone scan index: a new biomarker for bone metastasis in patients with prostate cancer. Int J Urol. 2017;24(9):668–73.
https://doi.org/10.1111/iju.13386
.
2. Scher HI, Morris MJ, Larson S, Heller G. Validation and clinical utility of prostate cancer biomarkers. Nat Rev Clin Oncol. 2013;10:225–34.
3. Erdi YE, Humm JL, Imbriaco M, Yeung H, Larson SM. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401–6.
4. Imbriaco M, Larson SM, Yeung HW, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. Clin Cancer Res. 1998;4:1765–72.
5. Van den Wyngaert T, Strobel K, Kampen WU, et al. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43:1723–38.